Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

172-195 (Activation loop from InterPro)

Target domain

34-292 (Protein kinase domain)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

1 structures for O54988

Entry ID Method Resolution Chain Position Source
AF-O54988-F1 Predicted AlphaFoldDB

50 variants for O54988

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3409339462 88 H>Q No EVA
rs3409524430 92 V>F No EVA
rs3389538457 111 C>Y No EVA
rs3389511459 123 L>I No EVA
rs3389538500 164 T>S No EVA
rs3389511510 174 F>L No EVA
rs3389544829 188 D>N No EVA
rs241676065 263 S>A No EVA
rs3389557281 308 K>* No EVA
rs3389540989 367 T>I No EVA
rs212553921 393 A>S No EVA
rs3389539283 401 V>L No EVA
rs3389546224 413 T>I No EVA
rs3389494734 433 D>N No EVA
rs3389554704 447 E>* No EVA
rs38916703 448 E>G No EVA
rs3389540984 451 N>K No EVA
rs3389557297 453 R>K No EVA
rs36646746 483 Q>K No EVA
rs3389501440 493 Q>R No EVA
rs3389557244 516 V>F No EVA
rs3389494724 519 T>R No EVA
rs251565764 537 I>V No EVA
rs3389501393 538 T>I No EVA
rs3389549411 547 T>A No EVA
rs3389545489 548 D>Y No EVA
rs234345660 568 E>D No EVA
rs3389544858 588 E>D No EVA
rs261609285 592 A>T No EVA
rs3389453552 596 P>H No EVA
rs3389525255 629 A>T No EVA
rs220594819 634 P>S No EVA
rs1134047440 636 T>M No EVA
rs3389501409 666 S>N No EVA
rs219437584 691 E>G No EVA
rs3389546278 713 I>T No EVA
rs37013078 740 H>N No EVA
rs3389560497 750 T>I No EVA
rs259027719 756 N>T No EVA
rs3389554651 760 D>N No EVA
rs37241710 772 A>T No EVA
rs3389501406 840 Q>L No EVA
rs3389540976 850 L>M No EVA
rs3389549420 944 K>T No EVA
rs3389554658 1004 A>T No EVA
rs3407315659 1024 Q>L No EVA
rs3408613207 1025 L>V No EVA
rs3389544809 1031 M>L No EVA
rs3389540922 1200 V>L No EVA
rs3389539325 1224 P>H No EVA

No associated diseases with O54988

2 regional properties for O54988

Type Name Position InterPro Accession
domain Ubiquitin-conjugating enzyme E2 30 - 175 IPR000608
active_site Ubiquitin-conjugating enzyme, active site 103 - 118 IPR023313

Functions

Description
EC Number 2.7.11.1 Protein-serine/threonine kinases
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cell leading edge The area of a motile cell closest to the direction of movement.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.

6 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
identical protein binding Binding to an identical protein or proteins.
protein homodimerization activity Binding to an identical protein to form a homodimer.
protein kinase activity Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.
protein serine/threonine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.

8 GO annotations of biological process

Name Definition
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
cytoplasmic microtubule organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of structures formed of microtubules and associated proteins in the cytoplasm of a cell.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
protein autophosphorylation The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
protein phosphorylation The process of introducing a phosphate group on to a protein.
regulation of apoptotic process Any process that modulates the occurrence or rate of cell death by apoptotic process.
regulation of cell migration Any process that modulates the frequency, rate or extent of cell migration.
regulation of focal adhesion assembly Any process that modulates the frequency, rate or extent of focal adhesion formation, the establishment and maturation of focal adhesions.

15 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
E1BK52 STK10 Serine/threonine-protein kinase 10 Bos taurus (Bovine) PR
O94804 STK10 Serine/threonine-protein kinase 10 Homo sapiens (Human) PR
Q9H2G2 SLK STE20-like serine/threonine-protein kinase Homo sapiens (Human) PR
O55098 Stk10 Serine/threonine-protein kinase 10 Mus musculus (Mouse) PR
Q6P9R2 Oxsr1 Serine/threonine-protein kinase OSR1 Mus musculus (Mouse) PR
Q9Z1W9 Stk39 STE20/SPS1-related proline-alanine-rich protein kinase Mus musculus (Mouse) PR
P70218 Map4k1 Mitogen-activated protein kinase kinase kinase kinase 1 Mus musculus (Mouse) PR
Q61161 Map4k2 Mitogen-activated protein kinase kinase kinase kinase 2 Mus musculus (Mouse) SS
Q99JP0 Map4k3 Mitogen-activated protein kinase kinase kinase kinase 3 Mus musculus (Mouse) SS
Q99JT2 Stk26 Serine/threonine-protein kinase 26 Mus musculus (Mouse) PR
Q99KH8 Stk24 Serine/threonine-protein kinase 24 Mus musculus (Mouse) PR
Q9Z2W1 Stk25 Serine/threonine-protein kinase 25 Mus musculus (Mouse) PR
Q8BPM2 Map4k5 Mitogen-activated protein kinase kinase kinase kinase 5 Mus musculus (Mouse) PR
E9PTG8 Stk10 Serine/threonine-protein kinase 10 Rattus norvegicus (Rat) PR
Q0IHQ8 stk10 Serine/threonine-protein kinase 10 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MSFFNFRKIF KLGSEKKKKQ YEHVKRDLNP EEFWEIIGEL GDGAFGKVYK AQNKETNVLA
70 80 90 100 110 120
AAKVIDTKSE EELEDYMVEI DILASCDHPN IVKLLDAFYY ENNLWILIEF CAGGAVDAVM
130 140 150 160 170 180
LELERPLTES QIQVVCKQTL EALNYLHDNK IIHRDLKAGN ILFTLDGDIK LADFGVSAKN
190 200 210 220 230 240
TRTIQRRDSF IGTPYWMAPE VVMCETSKDR PYDYKADVWS LGITLIEMAE IEPPHHELNP
250 260 270 280 290 300
MRVLLKIAKS EPPTLAQPSK WSSNFKDFLR KCLEKNVDAR WTTSQLLQHP FVTVDSNKPV
310 320 330 340 350 360
RELIAEAKAE VTEEVEDGKE EDEEEEAENA LPIPANKRAS SDLSIASSEE DKLSQNACIL
370 380 390 400 410 420
ESVSERTEQS TSEDKFSNKI LNEKPTTDGP EKAVDEHASD VNLETGAELN DQTVGIHENG
430 440 450 460 470 480
REKKRPKLEN LPDTQDQQTV DVNSVSEENE NNRVTLETNT DCLKPEEDRN KENQETLESK
490 500 510 520 530 540
LIQSEEINDT HIQTMDLVSQ ETGEKEADFQ AVDNEVGLTK EETQEKLGKD GTAQKVITSD
550 560 570 580 590 600
RSSEVGTDEA LDDTQKAAEL SKAAQSGEGD EALAPTQTLA EKPTEGPEAG GAEEEPPGGE
610 620 630 640 650 660
RVEDKQPEQQ PAVCEAEGQL TSTSETTRAT LEQPETDEVE QVSESNSIEE LERLVVTGAE
670 680 690 700 710 720
ARALGSEGEA AATEVDLERK ENAQKVPVKA ESQAPAASQP SEPHPVLIPS ININSETTEN
730 740 750 760 770 780
KEEMGALPKP ETILPPEPEH EKGNDTDSGT GSTVENSSGD LNLSISSFLS KAKDSGSVSL
790 800 810 820 830 840
QETRRQKKTL KKTRKFIVDG VEVSVTTSKI VTDSDSKTEE LRFLRRQELR ELRLLQKEEQ
850 860 870 880 890 900
RAQQQLNGKL QQQREQIFRR FEQEMLSKKR QYDQEIENLE KQQKQTIERL EQEHTNRLRD
910 920 930 940 950 960
EAKRIKGEQE KELSKFQNVL KNRKKEVMNE VEKAPRELRR ELTKRRKEEL AQSQHAQEQE
970 980 990 1000 1010 1020
FVQKQQQELD GSLKKIIQQQ KAELANIERE CLNNKQQLMR AREAAIWELE ERHLQEKHQL
1030 1040 1050 1060 1070 1080
LKQQLKDQYF MQRHQLLKRH EKETEQMQRY NQRLIEELKN RQTQERARLP KIQRSEAKTR
1090 1100 1110 1120 1130 1140
MAMFKKSLRI NSTATPDQDR EKIKQFAAQE EKRQKNERMA QHQKHESQMR DLQLQCEANV
1150 1160 1170 1180 1190 1200
RELHQLQNEK CHLLVEHETQ KLKELDEEHS QELKEWREKL RPRKKTLEEE FARKLQEQEV
1210 1220 1230
FFKMTGESEC LNPSAQSRIS KFYPIPTLHS TGS